Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics' Shareholders OK Reverse Stock Split

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that its shareholders have approved a one-for-fifteen reverse stock split, which will take effect before trading opens Tuesday.

The reverse split was previously approved by the firm's board of directors and is intended to increase Rosetta's share price to satisfy the $1 minimum bid price requirement for remaining listed on the Nasdaq Capital Market. It had been notified by Nasdaq at the end of November that it was not in compliance with the $1 minimum bid rule and that it had until May 29 to regain compliance.

In mid-afternoon trade today, shares of Rosetta were down 9 percent at $.15 per share.

Following the reverse split, Rosetta will have 1,238,642 ordinary shares outstanding.

Rosetta received another warning letter from Nasdaq last month informing the firm that it also didn't satisfy a listing requirement of at least $2.5 million in stockholders equity. It has through June 1 to submit a plan detailing how it will regain compliance. If the Listing Qualifications Staff accepts the plan, Rosetta would receive an extension of up to 180 calendar days, or through Oct. 15, to regain compliance.

The cash-strapped microRNA test developer hasn't reported its first-quarter financial results yet.

It recently signed definitive agreements to sell 8.1 million shares of its stock to certain investors at $0.17 apiece, expecting to raise $1.4 million.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.